These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5658834)

  • 1. [Favorable effect of desferal on the clinical course of hemochromatosis].
    Miolin A; Radojicić B
    Vojnosanit Pregl; 1968 Mar; 25(3):144-5. PubMed ID: 5658834
    [No Abstract]   [Full Text] [Related]  

  • 2. [Desferal in the treatment of hemochromatosis].
    Pokora J; Matuszewski M; Sliwińska J
    Pol Tyg Lek; 1965 Aug; 20(32):1205-6. PubMed ID: 5845702
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of desferal and some data on hemosiderosis in hypo- and aplastic anemias].
    Fainshtein FE; Trubina NS; Sobaleva IuG; Rozanova NS; Voronina AN
    Probl Gematol Pereliv Krovi; 1968 Aug; 13(8):31-8. PubMed ID: 5736846
    [No Abstract]   [Full Text] [Related]  

  • 4. Desferal therapy in iron storage disease.
    Thompson RB; Owen DM; Bell WN
    Am J Med Sci; 1967 Apr; 253(4):453-60. PubMed ID: 6021380
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of desferal in anemia, myeloid leukemia and other pathological conditions].
    Kol'tsova GN; Meshchanov AIu
    Gematol Transfuziol; 1992; 37(9-10):44-6. PubMed ID: 1490576
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of hemochromatosis treated with desferrioxamine].
    Dowzenko A; Marecik-Piasecka G; Palynyczko Z
    Pol Tyg Lek; 1967 May; 22(18):678-9. PubMed ID: 6078337
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of primary hemochromatosis with deferoxamine.
    Young N; Henry W; Nienhuis AW
    JAMA; 1979 Mar; 241(11):1152-4. PubMed ID: 762769
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinically isolated cardiac hemochromatosis treated with success by desferrioxamine].
    Moretti G; Staeffen J; Galley P; Mulet M; Descamps F
    J Med Bord; 1965 Dec; 142(12):1983-6. PubMed ID: 5855516
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of desferrioxamine B and 2-(beta-aminoethoxy)cyclohexylaminetetraacetate in experimental hemochromatosis in rats and in primary hemochromatosis of man].
    Bohne F; Lessmann J
    Arzneimittelforschung; 1969 Jun; 19(6):944-7. PubMed ID: 5820039
    [No Abstract]   [Full Text] [Related]  

  • 10. [Desferrioxamine in patients with hemochromatosis and hemosiderosis].
    Maspes V; Tamigaki M; Gomes ZJ; Jamra M
    Rev Hosp Clin Fac Med Sao Paulo; 1966; 21(4):181-95. PubMed ID: 5918167
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemochromatosis and its modern treatment].
    Böttger G
    Z Gesamte Inn Med; 1967 Jun; 22(12):376-80. PubMed ID: 5593769
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contribution to the problem of hemochromatosis].
    Bruns W; Michaelis D; Takác A; Langsch HG
    Dtsch Z Verdau Stoffwechselkr; 1966 Feb; 25(6):363-70. PubMed ID: 5998360
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of primary hemochromatosis treated with desferol].
    Lawecki J; Rogala H
    Wiad Lek; 1966 Oct; 19(19):1543-7. PubMed ID: 5977345
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of desferal in treatment of sideroses of different origin. (Literature review)].
    Turbina NS
    Probl Gematol Pereliv Krovi; 1968 Jul; 13(7):47-52. PubMed ID: 4898933
    [No Abstract]   [Full Text] [Related]  

  • 15. Neonatal hemochromatosis: failure of deferoxamine therapy.
    Jonas MM; Kaweblum YA; Fojaco R
    J Pediatr Gastroenterol Nutr; 1987; 6(6):984-8. PubMed ID: 3681586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ocular side effects of deferoxamine therapy in aplastic anemia with transfusion-induced hemochromatosis].
    Spraul CW; Schicketanz C; Lang GE
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):31-6. PubMed ID: 8965474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the ion-exchange resin desferrioxamine B on iron metabolism].
    Keler-Bacoka M; Hahn A
    Lijec Vjesn; 1965 Dec; 87(12):1329-38. PubMed ID: 5880072
    [No Abstract]   [Full Text] [Related]  

  • 18. [Case of primary haemochromatosis and therapeutic effect of desferrioxamine].
    Tsujimoto T; Mitsutani N; Nagatomo T
    Nihon Rinsho; 1970 Apr; 28(4):1389-96. PubMed ID: 5464217
    [No Abstract]   [Full Text] [Related]  

  • 19. [First results of a new iron chelating agent in the treatment of post-transfusional hemochromatosis].
    Giraud P; Orsini A; Giraud F; Pinsard N
    Arch Fr Pediatr; 1965 Apr; 22(4):463-8. PubMed ID: 5826583
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myocardiopathy caused by iron deposition. Treatment with chelating agents].
    Rodríguez Reguero JJ; Iglesias Cubero G; Espolita Santos A; López de la Iglesia JM; Enríquez Martín J; Tomás Mauri J; López-Negrete L
    Rev Esp Cardiol; 1985; 38(5):356-7. PubMed ID: 4081244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.